SI
Silo Pharma, Inc.
SILO · NASDAQ
$1.84 +10.18% (+$0.17)
1M -28.68%
Market Cap $2.08M
P/E Ratio -
Div. Yield -
ROE 81.74%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/S 38.40x
P/B 0.42x
P/E N/A
Growth
16 /100
Declining Rev. growth 0.00%
Book val. growth 15.20%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 474.31%
Net margin 8,269.53%
Op. margin 8,250.46%
Quality
0 /100
Poor ROIC 91.31%
ROE 81.74%
ROA 75.13%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 5.36x
Int. coverage -115.27x
Stability
76 /100
Stable Beta 0.75x
Rev. volatility 0.00%
EPS volatility 28.58%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SILO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Weisblum
Employees
3
Headquarters
Sarasota
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report